Daily Tadalafil 5 mg Combined With On-Demand Sildenafil 100 mg for Treatment of Erectile Dysfunction in PDE-5I Non Responder Patients
Key facts
- Who runs it
- Mansoura University
- Where
- Egypt11 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- Phase
- Phase 4
- People taking part
- 500 people, planned
- Started
- 1 Dec 2025
- Expected to end
- Jun 2027
- Type of study
- Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- Tadalafil 5 mg & Sildenafil 100mg
- Sildenafil 100mg & placebo
- Record updated
- 6 February 2026
Who can take part
- Age
- 21 years and older
- Sex
- Men only
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Sexually active male
- History of ED for ≥6 months
- Erectile function domain of IIEF-15 score <17
- Documented failure to respond to PDE-5I [definition of non-responder patients are patients with ED who don't respond to maximum dose of PDE-5I on ≥4 occasions in spite of accurate timing and good sexual stimulation]
- Stable sexual relationship ≥ 6 months
Who cannot take part
- Pelvic surgery or radiation
- Previous penile surgery of any kind, such as penile prosthesis, penile lengthening, penile cancer surgery, penile plication or grafting
- Using other treatments for ED e.g., Intra-cavernoasl prostaglandin injection therapy
- Penile anatomical deformities or Peyronie's disease
- Active malignancy or severe systemic illness
- Contraindication to PDE5i (High risk cardiac patients, patients on nitrates, hypotension)
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this clinical trial is to evaluate whether daily dosing with tadalafil 5 mg combined with on-demand sildenafil 100 mg can improve erectile function in men with erectile dysfunction (ED) who do not respond to PDE5 inhibitor alone.
Read full original descriptionShow less
The main questions it aims to answer are:
* Does the combination of daily tadalafil and on-demand sildenafil lead to a greater improvement in erectile function (measured by the IIEF-EF domain) compared with on-demand sildenafil alone? * Is the combination therapy safe and well tolerated in this patient population?
Researchers will compare:
* Group A: Daily tadalafil 5 mg plus on-demand sildenafil 100 mg * Group B: Daily placebo plus on-demand sildenafil 100 mg
to determine whether the combination regimen provides superior improvement in erectile function and patient satisfaction.
Participants will:
* Undergo baseline assessment including medical history, physical examination, and laboratory tests. * Be randomly assigned to one of the two treatment groups. * Take the assigned medications for 12 weeks. * Complete follow-up evaluations at 4, 8, and 12 weeks, including:
International Index of Erectile Function (IIEF-15) questionnaire Erection Hardness Score (EHS) assessment Reporting of any adverse effects
The 2 groups in the trial
- Group ATreatment being tested
Daily tadalafil 5 mg and on-demand sildenafil 100 mg
Treatment: Tadalafil 5 mg & Sildenafil 100mg
- Group BPlacebo, for comparison
daily Placebo and on demand sildenafil 100 mg
Treatment: Sildenafil 100mg & placebo
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Daily Tadalafil 5 mg Combined With On-Demand Sildenafil 100 mg for Treatment of Erectile Dysfunction in PDE-5I Non Responder Patients: A Multicenter Randomized, Double-Blind, Placebo-Controlled Trial
- Record updated
- 6 February 2026